Michael Prodanuk
@mprodanuk.bsky.social
Pediatric infectious diseases physician, grad student, TB/NTM fellow, TB epidemiology and biomarkers (he/him)
🧸 Centre for Global Child Health & Division of Infectious Diseases, SickKids
📚 IHPME, University of Toronto
🧸 Centre for Global Child Health & Division of Infectious Diseases, SickKids
📚 IHPME, University of Toronto
Reposted by Michael Prodanuk
Adverse events of first-line therapy for pediatric tuberculosis: A systematic review and meta-analysis
✅ Just Accepted
✍️ @mpnuk.bsky.social
#IDSky
✅ Just Accepted
✍️ @mpnuk.bsky.social
#IDSky
Adverse events of first-line therapy for pediatric tuberculosis: A systematic review and meta-analysis
In 2010, the World Health Organization (WHO) increased recommended doses of first-line tuberculosis (TB) drugs for children.
doi.org
April 2, 2025 at 6:58 PM
Adverse events of first-line therapy for pediatric tuberculosis: A systematic review and meta-analysis
✅ Just Accepted
✍️ @mpnuk.bsky.social
#IDSky
✅ Just Accepted
✍️ @mpnuk.bsky.social
#IDSky